Directed by our video director, Lee Cummings, this project brought together expert storytelling and polished production to cover Algernon Pharmaceuticals’ groundbreaking research on DMT as a potential treatment for stroke. Filmed as part of the StreetWise Live series, the segment featured in-depth interviews with Algernon CEO Chris Moreau and AlphaNorth Asset Management CEO Steve Palmer, offering viewers both the scientific and investment perspectives on this cutting-edge biotech development.

Our production approach balanced medical and technical information with compelling visuals and a crisp edit. The discussion explored the staggering need for new stroke treatments, how DMT’s neuroplasticity-enhancing effects could revolutionize recovery, and why this research has captured investor attention. We ensured that the pacing, graphics, and on-screen cues made the content accessible to both seasoned biotech investors and general audiences.